We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$330M
Cap. Flow %
8.14%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2 quarters
Top 10 Avg Time Held Equity + Options
1.2 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.2 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
K icon
Kellanova
K
+$269M
2
SRCL icon
Stericycle Inc
SRCL
+$141M
3
MRO icon
Marathon Oil Corporation
MRO
+$108M
4
CHX icon
ChampionX
CHX
+$103M
5
SPR icon
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN icon
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X icon
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BSX icon
326
Boston Scientific
BSX
$62.6B
$572K 0.01%
6,827
-273
-4% -$21.5K
2022 Q1
10 quarters
RIG icon
327
PUT
Transocean
RIG
$6.22B
$567K 0.01%
403,400
– –
2018 Q2
25 quarters
ACRV icon
328
Acrivon Therapeutics
ACRV
$82.7M
$555K 0.01%
79,249
-26,000
-25% -$205K
2023 Q2
5 quarters
F icon
329
PUT
Ford
F
$47.9B
$547K 0.01%
570,900
– –
2022 Q2
9 quarters
EWTX icon
330
Edgewise Therapeutics
EWTX
$4.21B
$534K 0.01%
20,000
-65,008
-76% -$1.29M
2022 Q2
9 quarters
SDGR icon
331
Schrodinger
SDGR
$1.95B
$525K 0.01%
28,316
+8,305
+42% +$171K
2022 Q1
10 quarters
IWM icon
332
CALL
iShares Russell 2000 ETF
IWM
$78.5B
$522K 0.01%
+160,000
New +$34.2M
2024 Q3
0 quarters
PTON icon
333
PUT
Peloton Interactive
PTON
$2.26B
$518K 0.01%
500,000
– –
2023 Q1
6 quarters
EPR icon
334
EPR Properties
EPR
$4.21B
$510K 0.01%
10,400
-1,800
-15% -$82.2K
2024 Q1
2 quarters
ALLK icon
335
DELISTED
Allakos
ALLK
$508K 0.01%
777,702
+61,137
+9% +$44.3K
2024 Q1
2 quarters
MRUS icon
336
DELISTED
Merus
MRUS
$496K 0.01%
9,922
+922
+10% +$48.1K
2022 Q1
10 quarters
RCUS icon
337
Arcus Biosciences
RCUS
$3.11B
$487K 0.01%
31,862
-33,325
-51% -$525K
2022 Q2
9 quarters
MGM icon
338
PUT
MGM Resorts International
MGM
$7.32B
$481K 0.01%
125,000
-125,000
-50% -$4.94M
2023 Q1
6 quarters
EW icon
339
Edwards Lifesciences
EW
$49.3B
$462K 0.01%
+7,000
New +$509K
2024 Q3
0 quarters
GLW icon
340
Corning
GLW
$128B
$452K 0.01%
+10,000
New +$421K
2024 Q3
0 quarters
VTYX icon
341
DELISTED
Ventyx Biosciences
VTYX
$436K 0.01%
+200,000
New +$460K
2024 Q3
0 quarters
HLF icon
342
PUT
Herbalife
HLF
$1.41B
$424K 0.01%
82,400
– –
2024 Q1
2 quarters
CYPH icon
343
Cypherpunk Technologies Inc
CYPH
$323M
$424K 0.01%
165,108
+15,336
+10% +$37.6K
2023 Q1
6 quarters
ARDX icon
344
Ardelyx
ARDX
$831M
$418K 0.01%
60,736
-23,857
-28% -$141K
2023 Q3
4 quarters
CGON icon
345
CG Oncology
CGON
$5.62B
$416K 0.01%
11,024
+1,024
+10% +$35.9K
2024 Q2
1 quarter
VSAT icon
346
PUT
Viasat
VSAT
$9.5B
$407K 0.01%
73,300
– –
2024 Q2
1 quarter
CRGX icon
347
DELISTED
CARGO Therapeutics
CRGX
$407K 0.01%
22,048
+2,048
+10% +$36.6K
2024 Q2
1 quarter
TERN icon
348
DELISTED
Terns Pharmaceuticals
TERN
$400K 0.01%
+48,000
New +$395K
2024 Q3
0 quarters
BDTX icon
349
Black Diamond Therapeutics
BDTX
$103M
$395K 0.01%
90,706
-213,000
-70% -$1.16M
2024 Q1
2 quarters
SABR icon
350
PUT
Sabre
SABR
$763M
$393K 0.01%
688,600
– –
2024 Q2
1 quarter
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.